Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes

Kami Pekayvaz(LMU Klinikum), Corinna Losert(Helmholtz Zentrum München), Viktoria Knottenberg(LMU Klinikum), Christoph Gold(LMU Klinikum), Irene V. van Blokland(University Medical Center Groningen), Roy Oelen(University Medical Center Groningen), Hilde E. Groot(University Medical Center Groningen), Jan Walter Benjamins(University Medical Center Groningen), Sophia Brambs(LMU Klinikum), Rainer Kaiser(LMU Klinikum), Adrian Gottschlich(LMU Klinikum), Gordon Victor Hoffmann(German Center for Lung Research), Luke Eivers(LMU Klinikum), Alejandro Martinez-Navarro(LMU Klinikum), Nils Bruns(LMU Klinikum), Susanne Stiller(LMU Klinikum), Sezer Akgöl(LMU Klinikum), Keyang Yue(LMU Klinikum), Vivien Polewka(LMU Klinikum), Raphael Escaig(LMU Klinikum), Markus Joppich(Ludwig-Maximilians-Universität München), Aleksandar Janjic(Ludwig-Maximilians-Universität München), Oliver Popp(Max Delbrück Center), Sebastian Kobold(Helmholtz Zentrum München), Tobias Petzold(LMU Klinikum), Ralf Zimmer(Ludwig-Maximilians-Universität München), Wolfgang Enard(Ludwig-Maximilians-Universität München), Kathrin Saar(Max Delbrück Center), Philipp Mertins(Max Delbrück Center), Norbert Huebner(Max Delbrück Center), Pim van der Harst(University Medical Center Utrecht), Lude Franke(University Medical Center Groningen), Monique G.P. van der Wijst(University Medical Center Groningen), Steffen Maßberg(LMU Klinikum), Matthias Heinig(Helmholtz Zentrum München), Leo Nicolai(LMU Klinikum), Konstantin Stark(LMU Klinikum)
Nature Medicine
May 21, 2024
Cited by 46Open Access
Full Text

Abstract

Acute and chronic coronary syndromes (ACS and CCS) are leading causes of mortality. Inflammation is considered a key pathogenic driver of these diseases, but the underlying immune states and their clinical implications remain poorly understood. Multiomic factor analysis (MOFA) allows unsupervised data exploration across multiple data types, identifying major axes of variation and associating these with underlying molecular processes. We hypothesized that applying MOFA to multiomic data obtained from blood might uncover hidden sources of variance and provide pathophysiological insights linked to clinical needs. Here we compile a longitudinal multiomic dataset of the systemic immune landscape in both ACS and CCS (n = 62 patients in total, n = 15 women and n = 47 men) and validate this in an external cohort (n = 55 patients in total, n = 11 women and n = 44 men). MOFA reveals multicellular immune signatures characterized by distinct monocyte, natural killer and T cell substates and immune-communication pathways that explain a large proportion of inter-patient variance. We also identify specific factors that reflect disease state or associate with treatment outcome in ACS as measured using left ventricular ejection fraction. Hence, this study provides proof-of-concept evidence for the ability of MOFA to uncover multicellular immune programs in cardiovascular disease, opening new directions for mechanistic, biomarker and therapeutic studies.


Related Papers

No related papers found

Powered by citation graph analysis